Synprosis Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Synprosis General Information

Description

Manufacturer of peptides intended for research and therapeutic applications. The company's products include resins, amino acids, coupling reagents, vaccines for malaria, cancer, allergies neurogenerative diseases and treatment of pain.

Contact Information

Website
www.synprosis.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 59, Avenue Sainte Victoire
  • Zac Saint Charles
  • 13710 Fuveau
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Bachem
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 59, Avenue Sainte Victoire
  • Zac Saint Charles
  • 13710 Fuveau
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synprosis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Synprosis‘s full profile, request access.

Request a free trial

Synprosis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synprosis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Synprosis‘s full profile, request access.

Request a free trial

Synprosis FAQs

  • When was Synprosis founded?

    Synprosis was founded in 2003.

  • Where is Synprosis headquartered?

    Synprosis is headquartered in Fuveau, France.

  • What is the size of Synprosis?

    Synprosis has 8 total employees.

  • What industry is Synprosis in?

    Synprosis’s primary industry is Drug Discovery.

  • Is Synprosis a private or public company?

    Synprosis is a Private company.

  • What is Synprosis’s current revenue?

    The current revenue for Synprosis is .

  • Who are Synprosis’s investors?

    Incubateur Impulse and Provepharm have invested in Synprosis.

  • When was Synprosis acquired?

    Synprosis was acquired on 01-Apr-2022.

  • Who acquired Synprosis?

    Synprosis was acquired by Bachem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process